GlycoMimetics (GLYC) Earnings Date, Estimates & Call Transcripts $0.17 -0.01 (-3.51%) Closing price 04:00 PM EasternExtended Trading$0.17 0.00 (-0.23%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GlycoMimetics Earnings Summary GlycoMimetics posted Q1 2025 earnings on May 14, 2025, reporting an EPS of -$0.04, which topped analysts' consensus estimates of -$0.05 by $0.01. With a trailing EPS of -$0.46, GlycoMimetics' earnings are expected to remain at ($0.08) per share in the coming year. Upcoming Q2 Earnings DateAug. 6Before Market OpensEstimatedConsensus EPS (May. 14) -$0.05 Actual EPS (May. 14) -$0.04 Beat By $0.01 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q)GLYC Upcoming EarningsGlycoMimetics' next earnings date is estimated for Wednesday, August 6, 2025, based on past reporting schedules. Powered by Get GlycoMimetics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GlycoMimetics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGLYC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GLYC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. GlycoMimetics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($0.08) EPSNext Year EPS Consensus Estimate ($0.08) EPS GlycoMimetics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/6/2025(Estimated)--------5/14/2025Q1 2025-$0.05-$0.04+$0.01-$0.04--2/13/2025Q4 2024-$0.16-$0.11+$0.05-$0.11--5/9/2024Q1 2024-$0.16-$0.17 -$0.01-$0.17--3/27/2024Q4 2023-$0.15-$0.14+$0.01-$0.14-$0.01M11/3/2023Q3 2023-$0.14-$0.14--$0.14--8/2/2023Q2 2023-$0.18-$0.13+$0.05-$0.13-- GlycoMimetics Earnings - Frequently Asked Questions When is GlycoMimetics's earnings date? GlycoMimetics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on GLYC's earnings history. Did GlycoMimetics beat their earnings estimates last quarter? In the previous quarter, GlycoMimetics (NASDAQ:GLYC) reported ($0.04) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.05) by $0.01. Learn more on analysts' earnings estimate vs. GLYC's actual earnings. How much revenue does GlycoMimetics generate each year? GlycoMimetics (NASDAQ:GLYC) has a recorded annual revenue of $10,000.00. How much profit does GlycoMimetics generate each year? GlycoMimetics (NASDAQ:GLYC) has a recorded net income of -$37.88 million. GLYC has generated -$0.46 earnings per share over the last four quarters. What is GlycoMimetics's EPS forecast for next year? GlycoMimetics's earnings are expected to stay at ($0.08) per share in the next year. More Earnings Resources from MarketBeat Related Companies RenovoRx Earnings Date Annovis Bio Earnings Date Prelude Therapeutics Earnings Date Adverum Biotechnologies Earnings Date Actinium Pharmaceuticals Earnings Date Applied Therapeutics Earnings Date Shattuck Labs Earnings Date Verrica Pharmaceuticals Earnings Date Renovaro Earnings Date Cue Biopharma Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:GLYC) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlycoMimetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlycoMimetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
